Prescribing Information for ▼PAXLOVID (nirmatrelvir / ritonavir) can be found here: Great Britain and Northern Ireland. Adverse event reporting information can be found at the bottom of the page. Please note, there are differences between the SmPC for Northern Ireland and the SmPC for Great Britain. Please refer to the appropriate SmPC depending on where you are based.

Paxlovid has a Conditional Marketing Authorisation in Great Britain. A Conditional Marketing Authorisation means that further evidence on this medicinal product is awaited. New information on this medicinal product will be reviewed when any relevant information of significance becomes available and at least every year and the product information will be updated as necessary.

• Paxlovid can be taken with or without food (see section 5.2 of the SmPC (GB or NI))
• The tablets should be swallowed whole and not chewed, broken, or crushed
• If a dose is missed and it is within 8 hours of the normal dosing schedule, the patient should take the dose immediately and resume their normal schedule
• If a dose is missed and it is more than 8 hours after the normal dosing schedule, the patient should not take the missed dose and should instead take their next dose at their regularly scheduled time
• If a patient requires hospitalization due to severe or critical COVID-19 after starting treatment with Paxlovid, the patient should complete the full 5-day treatment course at the discretion of his/her healthcare provider
• Nirmatrelvir must be coadministered with ritonavir. Failure to correctly coadminister nirmatrelvir with ritonavir will result in plasma concentrations of nirmatrelvir that will be insufficient to achieve the desired therapeutic effect

• Ritonavir is administered with nirmatrelvir as a pharmacokinetic enhancer^1,2

• Ritonavir is not active against SARS-CoV-2 3CL protease. It inhibits the CYP3A-mediated metabolism of nirmatrelvir, thereby providing increased plasma concentrations of nirmatrelvir^1,2
• Ritonavir is used in combination with other antivirals to similarly inhibit drug metabolism³

Find information on dose adjustments here. 

For Great Britain HCPs only: Search the Interaction Finder to easily search for drug interactions by drug name.